絞り込み

16731

広告

「J Thorac Oncol[Journal]」の検索結果

4608件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Smoking Cessation After a Cancer Diagnosis Is Associated With Improved Survival.

Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome.

Immune checkpoint inhibitors in thoracic malignancies: Review of the existing evidence by an IASLC expert panel and recommendations.

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in second-line treatment of patients with non-small cell lung cancer: results from an expansion cohort of a phase 1 trial.

Non-small-cell lung cancer immunotherapy efficacy and antibiotic use: a systematic review and meta-analysis.

Cost-effectiveness of follow-up for subsolid pulmonary nodules in high-risk patients.

Alterations in the PI3K pathway drive resistance to MET inhibitors in NSCLC harboring MET exon 14 skipping mutations.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States.

Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in non-small cell lung cancer.

Editorial: Coronaviruses: Facts, Myths and Hypotheses.

Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE).

The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2.

Assessing Outcomes of Patients Treated with Re-irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction.

Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced Non-Small Cell Lung Cancer.

Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus.

A Novel Oncogenic RET Fusion Variant in Non-Small Cell Lung Cancer: RELCH-RET.

Intracardiac Involvement by Primary Malignant Mesothelioma: A Report of Two Cases.

STRN3-NTRK1: A Novel NTRK1 Oncogenic Fusion in a Patient with Lung Adenocarcinoma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります